SEC Form 4 · accession 0001437749-18-003132
NAVIDEA BIOPHARMACEUTICALS, INC. · NAVB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Frederick O Cope
Officer — SVP & CSO
Period of report
Feb 20, 2018
Accepted (ET)
Feb 22, 2018 · 5:35 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000810509
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 20, 2018 | A | 135,694 | $0.36 | A | 372,662 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Granted in lieu of cash bonus under the 2017 bonus plan.